Peter Saranchuk

1.1k total citations
24 papers, 789 citations indexed

About

Peter Saranchuk is a scholar working on Infectious Diseases, Epidemiology and Ophthalmology. According to data from OpenAlex, Peter Saranchuk has authored 24 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 16 papers in Epidemiology and 6 papers in Ophthalmology. Recurrent topics in Peter Saranchuk's work include Tuberculosis Research and Epidemiology (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers) and Infectious Diseases and Tuberculosis (5 papers). Peter Saranchuk is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers) and Infectious Diseases and Tuberculosis (5 papers). Peter Saranchuk collaborates with scholars based in South Africa, Uganda and India. Peter Saranchuk's co-authors include Petros Isaakidis, Homa Mansoor, Nathan Ford, Eric Goemaere, Giovanni Battista Migliori, Mrinalini Das, Giovanni Sotgiu, Camilla Rodrigues, Katherine Hilderbrand and Helen Cox and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and PLoS Medicine.

In The Last Decade

Peter Saranchuk

24 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Saranchuk South Africa 16 500 498 155 144 100 24 789
Rosemary J. Burnett South Africa 19 277 0.6× 884 1.8× 55 0.4× 29 0.2× 31 0.3× 49 1.1k
Homa Mansoor South Africa 14 404 0.8× 287 0.6× 21 0.1× 101 0.7× 48 0.5× 30 510
Ruth Goodall United Kingdom 16 597 1.2× 242 0.5× 19 0.1× 80 0.6× 370 3.7× 47 893
Nadim Salomon United States 19 619 1.2× 643 1.3× 11 0.1× 209 1.5× 33 0.3× 31 868
Kathleen Squires United States 11 432 0.9× 267 0.5× 23 0.1× 74 0.5× 325 3.3× 17 817
Ann M. Labriola United States 10 523 1.0× 256 0.5× 13 0.1× 47 0.3× 294 2.9× 14 757
Achara Chaovavanich Thailand 12 535 1.1× 379 0.8× 7 0.0× 69 0.5× 150 1.5× 21 703
Usha Mathur United States 6 300 0.6× 467 0.9× 45 0.3× 20 0.1× 154 1.5× 6 605
Nicolas Durier Thailand 11 163 0.3× 227 0.5× 41 0.3× 12 0.1× 94 0.9× 22 371
Christopher Gilpin Switzerland 18 344 0.7× 345 0.7× 25 0.2× 127 0.9× 9 0.1× 30 622

Countries citing papers authored by Peter Saranchuk

Since Specialization
Citations

This map shows the geographic impact of Peter Saranchuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Saranchuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Saranchuk more than expected).

Fields of papers citing papers by Peter Saranchuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Saranchuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Saranchuk. The network helps show where Peter Saranchuk may publish in the future.

Co-authorship network of co-authors of Peter Saranchuk

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Saranchuk. A scholar is included among the top collaborators of Peter Saranchuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Saranchuk. Peter Saranchuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saranchuk, Peter, et al.. (2020). Inuit communities can beat COVID-19 and tuberculosis. The Lancet Public Health. 5(6). e312–e312. 2 indexed citations
2.
Heiden, David, Peter Saranchuk, Jeremy D. Keenan, et al.. (2016). Eye examination for early diagnosis of disseminated tuberculosis in patients with AIDS. The Lancet Infectious Diseases. 16(4). 493–499. 24 indexed citations
3.
Das, Mrinalini, et al.. (2015). Double trouble: tuberculosis and substance abuse in Nagaland, India. Public Health Action. 5(3). 180–182. 1 indexed citations
4.
Ardizzoni, Elisa, Emmanuel Fajardo, Peter Saranchuk, et al.. (2015). Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries. PLoS ONE. 10(12). e0144656–e0144656. 43 indexed citations
5.
Das, Mrinalini, Prashant N. Chhajed, Sujeet Rajan, et al.. (2015). Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Greater Metropolitan Mumbai: Trends over Time. PLoS ONE. 10(1). e0116798–e0116798. 54 indexed citations
6.
Isaakidis, Petros, et al.. (2014). Infection control in households of drug-resistant tuberculosis patients co-infected with HIV in Mumbai, India. Public Health Action. 4(1). 35–41. 1 indexed citations
7.
Isaakidis, Petros, Mrinalini Das, Ajay Kumar, et al.. (2014). Alarming Levels of Drug-Resistant Tuberculosis in HIV-Infected Patients in Metropolitan Mumbai, India. PLoS ONE. 9(10). e110461–e110461. 44 indexed citations
8.
Martínez‐Pérez, Guillermo Z., et al.. (2014). Barriers to pilot mobile teleophthalmology in a rural hospital in Southern Malawi. Pan African Medical Journal. 19. 16 indexed citations
9.
Das, Mrinalini, et al.. (2014). Self-Administered Tuberculosis Treatment Outcomes in a Tribal Population on the Indo-Myanmar Border, Nagaland, India. PLoS ONE. 9(9). e108186–e108186. 9 indexed citations
10.
Saranchuk, Peter, et al.. (2014). Patch-testing for the management of hypersensitivity reactions to second-line anti-tuberculosis drugs: a case report. BMC Research Notes. 7(1). 537–537. 4 indexed citations
11.
Isaakidis, Petros, et al.. (2013). Poor Outcomes in a Cohort of HIV-Infected Adolescents Undergoing Treatment for Multidrug-Resistant Tuberculosis in Mumbai, India. PLoS ONE. 8(7). e68869–e68869. 50 indexed citations
12.
Ford, Nathan, Zara Shubber, Peter Saranchuk, et al.. (2013). Burden of HIV-Related Cytomegalovirus Retinitis in Resource-Limited Settings: A Systematic Review. Clinical Infectious Diseases. 57(9). 1351–1361. 64 indexed citations
13.
14.
Isaakidis, Petros, Mrinalini Das, Homa Mansoor, et al.. (2013). High Rate of Hypothyroidism in Multidrug-Resistant Tuberculosis Patients Co-Infected with HIV in Mumbai, India. PLoS ONE. 8(10). e78313–e78313. 23 indexed citations
15.
Isaakidis, Petros, Homa Mansoor, Helen Cox, et al.. (2012). Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India. PLoS ONE. 7(7). e40781–e40781. 75 indexed citations
16.
17.
Isaakidis, Petros, Helen Cox, Chiara Montaldo, et al.. (2011). Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India. PLoS ONE. 6(12). e28066–e28066. 67 indexed citations
18.
Cohen, Rachel, Helen Bygrave, Katherine Hilderbrand, et al.. (2009). Antiretroviral treatment outcomes from a nurse‐driven, community‐supported HIV/AIDS treatment programme in rural Lesotho: observational cohort assessment at two years. Journal of the International AIDS Society. 12(1). 23–23. 105 indexed citations
19.
Moon, Suerie, Luc Van Leemput, Nicolas Durier, et al.. (2008). Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough?. AIDS Care. 20(8). 984–994. 31 indexed citations
20.
Heiden, David, Nathan Ford, David J. Wilson, et al.. (2007). Cytomegalovirus Retinitis: The Neglected Disease of the AIDS Pandemic. PLoS Medicine. 4(12). e334–e334. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosemary J. Burnett Breakdown of academic impact, for papers by Homa Mansoor Breakdown of academic impact, for papers by Ruth Goodall Breakdown of academic impact, for papers by Nadim Salomon Breakdown of academic impact, for papers by Kathleen Squires Breakdown of academic impact, for papers by Ann M. Labriola Breakdown of academic impact, for papers by Achara Chaovavanich Breakdown of academic impact, for papers by Usha Mathur Breakdown of academic impact, for papers by Nicolas Durier Breakdown of academic impact, for papers by Christopher Gilpin
Rankless by CCL
2026